Pretreatment clinical and genetic factors predict early post-treatment mortality in fit AML patients following induction.
Am J Hematol
; 96(7): E259-E262, 2021 07 01.
Article
in En
| MEDLINE
| ID: mdl-33837971
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myeloid, Acute
/
Anthracyclines
/
Cytarabine
/
Induction Chemotherapy
/
Antineoplastic Agents
Type of study:
Diagnostic_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Humans
/
Middle aged
Language:
En
Journal:
Am J Hematol
Year:
2021
Document type:
Article
Affiliation country:
United States